Biochemical and structural characterization of a DNA N6-adenine methyltransferase from Helicobacter pylori

Bo Ma1, Ji Ma1, Dong Liu2

  • 1Department of Human Anatomy, Histology and Embryology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing, China.

Oncotarget
|June 5, 2016
PubMed

Insights

This study reveals the structural basis for DNA N6-adenine methyltransferase promiscuity in Helicobacter pylori. Understanding M1.HpyAVI

Area of Science:

  • Bacteriology
  • Molecular Biology
  • Structural Biology

Background:

  • DNA N6-methyladenine modification is crucial for bacterial biological functions.
  • The sequence-specific recognition mechanism of N6-methyladenine modification is not well understood.
  • M1.HpyAVI from Helicobacter pylori exhibits unusual substrate promiscuity compared to other methyltransferases.

Purpose of the Study:

  • To elucidate the structural basis of DNA N6-adenine methyltransferase (MTase) substrate promiscuity.
  • To investigate the cofactor-free and AdoMet-bound structures of M1.HpyAVI.
  • To identify key residues involved in cofactor binding, methyl transfer, and substrate specificity.

Main Methods:

  • X-ray crystallography to determine enzyme structures at 3.0 Å and 3.1 Å resolution.
  • Site-directed mutagenesis to probe the function of specific amino acid residues.
  • Biochemical assays to assess cofactor binding and methyl transfer activity.

Main Results:

  • The core structure of M1.HpyAVI shares the canonical AdoMet-dependent MTase fold.
  • Putative DNA binding regions of M1.HpyAVI differ significantly from other MTases, potentially explaining its promiscuity.
  • Residues D29 and E216 are critical for cofactor binding and methyl transfer.
  • Residue P41 in a flexible loop is key for determining substrate specificity.

Conclusions:

  • The study provides structural insights into the substrate promiscuity of DNA N6-adenine methyltransferases.
  • The unique structural features of M1.HpyAVI contribute to its broad substrate specificity.
  • Identification of key residues offers potential targets for enzyme engineering or drug development.